Fotona Appoints Jeff Duchemin as the New Group President and CEO

Fotona Welcomes Jeff Duchemin as New President and CEO

Fotona®, a global leader in high-performance laser systems and energy-based devices for aesthetic, dental, and gynecological applications, announced the appointment of Jeff Duchemin as its new President and Chief Executive Officer as of May 15, 2025. This strategic move sets the stage for the company's next phase of growth.

Jeff Duchemin brings a wealth of experience from the medical technology sector, spanning decades of leadership roles on both domestic and international fronts. His recent roles at Becton Dickinson included executive positions in Interventional Surgery and Integrated Diagnostic Solutions, showcasing his ability to navigate complex market landscapes. Before that, he served as President and CEO of Harvard Biosciences, where he successfully drove revenue growth both organically and through strategic acquisitions.

Duchemin's academic credentials include an MBA from Southern New Hampshire University and a Bachelor’s degree in Accounting from the University of Massachusetts Dartmouth. His deep understanding of the medical technology arena positions him well to lead Fotona into a future filled with innovation and expansion.

Jay Katzen, Fotona's Executive Chairman, expressed enthusiasm about Duchemin's appointment, stating, "Jeff is a visionary leader with a proven track record in advancing success within the life sciences and medical device industries. We look forward to his leadership as Fotona continues to innovate and maintain its market position."

In his first remarks as President and CEO, Duchemin emphasized the company’s enduring commitment to innovation. "Innovation is at the core of Fotona. I am passionate about accelerating our growth—enhancing our existing solutions while introducing new, groundbreaking technologies. Fotona has a strong foundation, exceptional talent, and top-tier products, making it an honor to lead the company during this crucial juncture in its journey."

Last year, Fotona celebrated an impressive milestone of 60 years in laser technology innovation. Over the decades, the company has consistently been at the forefront of industry advancements, including the revolutionary development of dual-wavelength laser integration (ErYAG and NdYAG) within a single system. A notable recent launch is the Dynamis® Max, a next-generation aesthetic platform known for its versatility, user-friendliness, and treatment efficiency, which supports over 100 advanced treatment applications.

As Fotona embarks on this new chapter under Duchemin's leadership, stakeholders are optimistic about the company's roadmap to enhance its global presence and further the advancements in laser technology that have defined its reputation for six decades.

For more information about Fotona and its innovative laser solutions, visit Fotona.com.

About Fotona

Fotona is a leading global company in medical lasers, recognized for its innovative and award-winning laser systems that cater to applications in aesthetics, dermatology, dentistry, surgery, and gynecology. With a highly qualified team, Fotona boasts an exceptionally high number of doctors specialized in laser innovation and medical technology. Besides its direct presence in the United States, China, Japan, and the EU, Fotona's global distribution network spans over 70 countries, ensuring comprehensive support and service to users of its laser technologies, including clinical training.